Acute Pancreatitis: Pathophysiology and Management
Pathophysiology
Acute pancreatitis is an inflammatory condition triggered by premature intracellular activation of pancreatic digestive enzymes, leading to autodigestion of pancreatic tissue and a systemic inflammatory cascade. 1
The pathophysiological sequence involves:
Enzymatic activation: Aberrant activation of trypsinogen to trypsin within acinar cells initiates the cascade, activating other digestive enzymes that destroy pancreatic parenchyma 2
Cellular injury mechanisms:
- Calcium overload in acinar cells
- Impaired autophagy
- Multiple forms of cell death (necrosis, apoptosis, necroptosis) 2
Systemic inflammation: The local pancreatic injury triggers systemic activation of:
- Coagulation cascades
- Kinin and complement systems
- Fibrinolytic pathways
- Cytokine release (TNF-α, IL-1, IL-6)
- Reactive oxygen metabolites 3
Progression to organ failure: When severe and overwhelming, this systemic response leads to:
- Shock
- Acute respiratory distress syndrome (ARDS)
- Acute kidney injury
- Multi-organ dysfunction syndrome 3
The most common etiologies are gallstones (45%), alcohol abuse (35%), and hypertriglyceridemia, with 10% remaining idiopathic. 3, 4
Classification and Risk Stratification
Use the 2012 Revised Atlanta Classification to categorize severity, as it directly correlates with mortality and guides management intensity. 1
Severity Categories:
Mild acute pancreatitis:
- No organ failure
- No local or systemic complications
- Usually resolves within first week 1
Moderately severe acute pancreatitis:
- Transient organ failure (<48 hours) OR
- Local complications OR
- Exacerbation of comorbid disease 1
Severe acute pancreatitis:
- Persistent organ failure (>48 hours)
- Hospital mortality ~15%
- Comprises 20-30% of cases 1
Critical Prognostic Factors:
Infected necrosis with organ failure carries 35.2% mortality, while sterile necrosis with organ failure has 19.8% mortality. 1 Infected necrosis without organ failure has only 1.4% mortality, emphasizing that organ failure—not infection alone—drives mortality 1.
Initial Management Approach
Immediate Assessment (First 24-48 Hours)
Perform ultrasound on admission to identify biliary etiology, as this determines need for definitive treatment during the same hospitalization. 1
Obtain contrast-enhanced CT only if:
- Diagnosis is uncertain
- Patient has predicted severe disease at 72-96 hours after symptom onset (optimal timing for detecting necrosis) 1
Early CT does not modify management in the first week and will miss necrotic areas 1.
Fluid Resuscitation
Initiate early goal-directed fluid resuscitation with isotonic crystalloids immediately upon diagnosis to optimize tissue perfusion, without waiting for hemodynamic deterioration. 1
Key Principles:
Monitor: Hematocrit, blood urea nitrogen, creatinine, and lactate as markers of volemia and tissue perfusion 1
Ringer's lactate may have anti-inflammatory advantages over normal saline, though evidence for superiority is weak 1, 5
Critical caveat: Fluid overload has detrimental effects—frequent reassessment of hemodynamic status is mandatory 1
Adjust volume to patient's age, weight, and pre-existing cardiac/renal conditions 1
Pain Management
Use dilaudid as first-line opioid in non-intubated patients; consider epidural analgesia for severe cases requiring prolonged high-dose opioids. 1
- NSAIDs should be avoided in acute kidney injury 1
- Patient-controlled analgesia (PCA) should be integrated in a multimodal approach 1
- All patients must receive analgesia within first 24 hours 1
Nutritional Support
Begin enteral nutrition early (oral, nasogastric, or nasojejunal) to prevent gut failure and infectious complications—this is superior to parenteral nutrition. 1
Feeding Strategy:
Mild pancreatitis: Regular diet, advance as tolerated 6
Moderately severe/severe pancreatitis:
If enteral route not tolerated: Consider partial parenteral nutrition to meet caloric/protein requirements, but avoid total parenteral nutrition 1
Rationale: Enteral feeding maintains gut mucosal barrier and prevents bacterial translocation 1.
Antibiotic Therapy
Do not give prophylactic antibiotics routinely—they are not associated with decreased mortality or morbidity in acute pancreatitis. 6, 5
When to Use Antibiotics:
Administer antibiotics only for documented or strongly suspected infected necrotizing pancreatitis. 6
Empiric Regimens for Infected Necrosis:
For patients without MDR risk:
- Meropenem 1g q6h by extended infusion OR
- Imipenem/cilastatin 500mg q6h by extended infusion OR
- Doripenem 500mg q8h by extended infusion 6
For patients with MDR risk factors:
- Imipenem/cilastatin-relebactam 1.25g q6h OR
- Meropenem/vaborbactam 2g/2g q8h OR
- Ceftazidime/avibactam 2.5g q8h + Metronidazole 500mg q8h 6
Duration: Limit to 7 days if source control is adequate; do not exceed 14 days without positive cultures 7, 6
ICU Admission Criteria
Transfer to ICU if persistent organ failure (>48 hours) occurs despite adequate fluid resuscitation. 1
Continuous vital signs monitoring in high dependency unit is needed if any organ dysfunction develops 1.
Management of Biliary Pancreatitis
ERCP Indications:
Perform urgent ERCP (within 72 hours) in biliary pancreatitis with:
Do not perform routine ERCP in all patients with gallstone pancreatitis—it provides no benefit without cholangitis or obstruction. 1, 5
Cholecystectomy Timing:
Perform cholecystectomy during the same hospital admission for mild biliary pancreatitis to prevent potentially fatal recurrent pancreatitis. 7
- Delay cholecystectomy in severe pancreatitis until lung injury and systemic disturbance resolve 7
- If definitive treatment cannot occur during admission, ensure clear plan for completion within 2 weeks 7
Management of Necrotizing Pancreatitis
Intervention Indications:
Intervene for infected necrosis only when clinical deterioration occurs with signs or strong suspicion of infection. 1
Step-Up Approach:
Begin with percutaneous or endoscopic drainage as first-line treatment—this delays or eliminates need for surgery in 25-60% of patients. 1
Timing of Intervention:
Postpone surgical interventions until >4 weeks after disease onset—this significantly reduces mortality. 1
Before 4 weeks, intervene only for:
- Infected necrosis with clinical deterioration
- Abdominal compartment syndrome unresponsive to conservative measures
- Acute ongoing bleeding when endovascular approach fails
- Bowel ischemia 1
After 4 weeks, consider intervention for:
- Ongoing organ failure without infected necrosis
- Gastric outlet, biliary, or intestinal obstruction from walled-off necrosis
- Disconnected duct syndrome
- Symptomatic or growing pseudocyst 1
Surgical Strategy:
When percutaneous/endoscopic drainage fails, use minimally invasive techniques (VARD, transgastric endoscopic necrosectomy) rather than open surgery—these result in less new-onset organ failure. 1
However, minimally invasive approaches require more interventions, and no mortality difference exists between techniques 1. The choice should be individualized based on local expertise and necrosis characteristics 1.
Special Considerations
Diagnosis of Infected Necrosis:
Use procalcitonin as the most sensitive test—low values strongly predict absence of infected necrosis. 6
Perform CT- or EUS-guided fine needle aspiration for Gram stain and culture in patients with:
30% pancreatic necrosis with persistent symptoms OR
- Smaller necrosis with clinical suspicion of sepsis 7, 6
Optimal timing is 7-14 days after onset 7.
Pharmacologic Agents:
No specific pharmacological treatment (gabexate mesilate, somatostatin analogues) should be given—only organ support and nutrition are beneficial. 1
Key Pitfalls to Avoid
Fluid overload: While early aggressive resuscitation is critical, excessive fluids worsen outcomes—reassess frequently 1
Routine prophylactic antibiotics: These do not prevent infection or improve outcomes and promote resistance 6, 5
Early surgery: Operating before 4 weeks dramatically increases mortality unless emergency indications exist 1
Routine ERCP: Only perform for cholangitis or documented obstruction, not for all gallstone pancreatitis 1, 5
Delayed cholecystectomy: Failure to perform definitive biliary treatment during index admission or within 2 weeks exposes patients to potentially fatal recurrent pancreatitis 7
Total parenteral nutrition: Enteral nutrition is superior and should be attempted first, even via nasogastric route 1